PRF1 and neoplasm: The TRAIL-R2xCD3 BsAb mechanism of action is based on three consecutive steps, including the formation of a bridge between tumor and T cells, the activation of T cells, and the subsequent release of granzyme B and perforin that induce tumor cell killing [6].